 |
| |
IN THIS ISSUE |
| |
2006 User Group
Migrate to V7
SW Symposium
Low occult bleeding
Elderly at risk
|
 |
 |
Welcome to Dawn AC September 2006 edition of the DAWN AC
Anticoagulation Software E-Newsletter.
We have
lots to tell you this month including an invite to an
symposium in Albuquerque later on this month.
|
2006 User Group... |
 |
 |
 |
 |
... Was a huge success for the fourteenth time running!
All of the talks were excellent. Our special thanks to the
speakers.
I am delighted to discover from the feedback surveys, that
every one of you that attended said you would come again
and that the hotels, meals and conference centre were up
to a good standard for all of you.
"The best meeting ever" was a common comment.
I am also pleased to hear that you all enjoyed the steamer
boat ride so much, I was relieved to see people net
working so well and that the rain held off until right at
the end.
I hope to put the talk write ups and presentations on our
website in the coming weeks.
I look forward to seeing you all there next year!
|
 |
 |
|
Migrate
to V7 |
 |
 |
|
Many of you have had quotations for upgrading to v7 we are
now pleased to announce that because of improved processes
the costs for this have been reduced. Please call us for
an updated quote.
Remember Dawn AC v7 has been completely and carefully
redesigned, using advanced design methodologies, for the
frequent user. It has a patent pending colour coding
system and display to give an outstandingly easy to use,
comprehensive and safe interface. It continues to be based
on the proven proprietary Dawn AC dosage adjustment
algorithm.
-
Is highly configurable so that customers achieve the
highest levels of fitness of purpose to meet their local
practice.
-
It works with most common browsers to give outstanding
response time performance and reliability. It has the
capacity to handle district-wide, regional or even
national systems.
-
Ability to interface other healthcare software systems
using HL7 protocols to facilitate integration with
coexisting centralised electronic medical record and
laboratory systems.
-
A powerful messaging capability is provided to handle
all types of events e.g. High INRs, so that all parties
are appropriately informed by telephone, email, SMS, or
mail.
Customers who have had a preview of the system have given
an extremely positive response and are so excited by the
concepts in this new product design.
|
|
SW
Symposium on Thrombosis |
 |
 |
|
South West Symposium on Thrombosis and Haemostasis,
Albuquerque,
New Mexico, 13-14th
October 2006
If you are attending the
above symposium, I invite you to come and visit our booth.
I would like to show you how our Dawn AC anticoagulation
software can boost safety and productivity.
If you are
unable to attend the symposium, but would still like
some information on our product and services then please
do not hesitate to contact us as we will be happy to
arrange an internet demonstration for you.
We hope
to see you there!
|
|
Low
Occult Bleeding |
 |
 |

Low occult bleeding levels
with aspirin, warfarin use in post-MI patients.
The use of aspirin, warfarin, or both drugs by patients
after myocardial infarction (MI) does not appear to result
in significant levels of occult bleeding with anemia or
iron deficiency.
In general, only macroscopic bleedings during treatment
with these antithrombotic drugs are of clinical
relevance, and that screening for occult bleeding yields
limited further information. These findings perhaps go
some way to allay anxieties over bleeding with the use
or abuse of anticoagulant therapies.
To read the rest of this article please follow the link
below:
|
|
Elderly
at Risk of Drug Errors |
 |
 |
695 people aged 78 to 86 living in sheltered housing were
surveyed and it revealed half were taking more than five
different medicines a day. Some 14% of the sample
were using highly toxic medications such as warfarin.
The risk of making mistakes was increased by frequent
changes in elderly people's medication routines.
The article suggests that Pharmacists could help ensure
patients were taking their drugs properly by carrying
out medication reviews.
To read the rest of this article please follow the link
below:
|
|